ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
타이로젠 시장 규모는 최근 몇 년간 크게 성장했습니다. 2025년 117만 달러에서 2026년에는 127만 달러에 이르고, CAGR 8.5%의 성장이 전망되고 있습니다. 지난 수년간의 성장은 갑상선 호르몬 금단증상 회피의 필요성, 갑상선암 발생률 증가, 병원 내 영상진단의 보급, TSH 자극검사의 임상적 유효성 확인, 방사성 요오드 검사에 대한 의존도 증가 등이 주요 요인으로 꼽힙니다.
타이로젠 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 174만 달러에 이르고, CAGR은 8.1%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 갑상선암 검진 확대, 진단 정확도 향상, 외래 진단센터 증가, 환자의 삶의 질(QOL)에 대한 관심 증가, 내분비종양학에 대한 투자 증가 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 갑상선암 모니터링 도구의 사용 확대, 환자 친화적인 진단 프로토콜로의 전환, 방사성 요오드 기반 진단법의 확대, 갑상선 절제술 후 치료의 채택 증가, 내분비 종양학 치료 결과의 개선 등이 있습니다.
갑상선암 발생률 증가는 향후 몇 년 동안 타이로젠 시장의 성장을 견인할 것으로 예측됩니다. 갑상선암은 갑상선에 발생하며 종종 목에 혹이나 결절로 나타납니다. 이러한 발생률 증가는 주로 첨단 영상진단 및 생검 기술의 발전으로 인한 검출률 향상과 방사선 노출 및 환경 변화 등의 요인에 기인합니다. 타이로젠은 갑상선암 치료에서 갑상선을 자극하여 잔존암의 발견을 돕고, 방사성 요오드 치료의 효과를 높이기 위해 사용됩니다. 예를 들어, 2024년 1월 미국암협회가 발표한 예측에 따르면 2024년 갑상선암 신규 환자 수는 2023년 43,720명에서 증가하여 약 44,020명(남성 12,500명, 여성 31,520명)에 달할 것으로 예상하고 있습니다. 또한, 갑상선암으로 인한 사망자 수는 약 2,170명으로 예상되며, 남성 990명, 여성 1,180명입니다. 이러한 갑상선암 발병률 증가는 갑상선암 치료제 시장의 성장을 견인하고 있습니다.
개인 맞춤형 의료에 대한 관심이 높아지는 것도 타이로젠 시장의 성장을 뒷받침할 것으로 예측됩니다. 맞춤형 의료는 환자 개개인의 고유한 유전적 특성, 생활습관, 환경적 특징에 따라 의료 개입을 조정하여 치료 결과를 개선하고 부작용을 감소시키는 것을 목표로 합니다. 타이로젠은 정밀의료, 특히 방사성 요오드 내성 질환을 가진 환자에서 갑상선 자극 호르몬 수용체를 활성화시켜 분화형 갑상선암에 대한 표적 진단 및 치료 중재를 제공하는 개인 맞춤형 치료제로서 점점 더 많이 활용되고 있습니다. 예를 들어, 2024년 2월 맞춤형 의료연합이 보고한 바에 따르면, 2023년 FDA가 희귀질환 환자를 위해 승인한 신규 개인맞춤형 치료제는 16건으로, 2022년 6건보다 증가했습니다. 이 중 7건은 암 치료, 3건은 기타 질환 및 증상에 대한 치료제로 승인됐습니다. 이처럼 개인 맞춤형 의료에 대한 관심이 높아지면서 타이로젠 시장의 성장을 견인하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 한국 시장
제17장 서유럽 시장
제18장 영국 시장
제19장 독일 시장
제20장 프랑스 시장
제21장 동유럽 시장
제22장 북미 시장
제23장 미국 시장
제24장 캐나다 시장
제25장 남미 시장
제26장 중동 시장
제27장 아프리카 시장
제28장 시장 규제 상황과 투자환경
제29장 경쟁 구도와 기업 개요
제30장 세계 시장 경쟁 벤치마킹과 대시보드
제31장 주요 인수합병(M&A)
제32장 시장 잠재력이 높은 국가, 부문, 전략
제33장 부록
LSH
영문 목차
영문목차
Thyrogen (thyrotropin alfa) is a synthetic thyroid-stimulating hormone used to detect residual thyroid cancer in patients who have undergone thyroid gland removal. It prompts the thyroid tissue to take up radioactive iodine for diagnostic imaging and treatment without requiring withdrawal from thyroid hormone therapy.
The main forms of Thyrogen are Vail and pre-filled. Vail Thyrogen refers to the use or distribution of thyrogen (thyrotropin alfa) by Genzyme in a specific setting, such as a medical facility or practice in Vail. It includes product forms like thyrogen powder and thyrogen injection, used for both diagnostic and therapeutic purposes. End users include hospitals, diagnostic centers, specialty clinics, and other medical facilities.
Tariffs have affected the thyrogen market by increasing costs for synthetic hormone production inputs, sterile packaging, and temperature-controlled logistics. These cost pressures have influenced pricing across hospital and diagnostic center channels, especially in import-dependent regions. Asia-pacific and latin america experience higher sensitivity due to limited domestic manufacturing. At the same time, tariffs have supported regional fill-finish operations, improved diagnostic supply stability, and strengthened long-term access to thyroid cancer monitoring solutions.
The thyrogen market research report is one of a series of new reports from The Business Research Company that provides thyrogen market statistics, including thyrogen industry global market size, regional shares, competitors with a thyrogen market share, detailed thyrogen market segments, market trends and opportunities, and any further data you may need to thrive in the thyrogen industry. This thyrogen market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The thyrogen market size has grown strongly in recent years. It will grow from $1.17 million in 2025 to $1.27 million in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to need to avoid thyroid hormone withdrawal, growth in thyroid cancer incidence, hospital-based diagnostic imaging, clinical validation of tsh stimulation, reliance on radioiodine scans.
The thyrogen market size is expected to see strong growth in the next few years. It will grow to $1.74 million in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to expansion of thyroid cancer screening, improved diagnostic accuracy, growth in outpatient diagnostic centers, rising patient quality-of-life focus, increased endocrine oncology investment. Major trends in the forecast period include growing use of thyroid cancer surveillance tools, shift toward patient-friendly diagnostic protocols, expansion of radioiodine-based diagnostics, rising adoption in post-thyroidectomy care, improved endocrine oncology outcomes.
The rising incidence of thyroid cancer is expected to drive the growth of the Thyrogen market in the coming years. Thyroid cancer originates in the thyroid gland and often presents as a lump or nodule in the neck. Its increasing incidence is largely due to improved detection through advanced imaging and biopsy techniques, as well as factors such as radiation exposure and environmental changes. Thyrogen is used in thyroid cancer management to stimulate the thyroid gland, aiding in the detection of residual cancer and enhancing the effectiveness of radioactive iodine therapy. For example, in January 2024, the American Cancer Society reported that approximately 44,020 new cases of thyroid cancer are expected, compared to 43,720 in 2023, including 12,500 in men and 31,520 in women. Additionally, around 2,170 deaths from thyroid cancer are anticipated, with 990 in men and 1,180 in women. Consequently, the rising incidence of thyroid cancer is driving the growth of the Thyrogen market.
The increasing focus on personalized medicine is also expected to support the growth of the Thyrogen market. Personalized medicine tailors healthcare interventions to the unique genetic, lifestyle, and environmental characteristics of individual patients, improving treatment outcomes and reducing adverse effects. Thyrogen is increasingly utilized in precision medicine to provide targeted diagnostic and therapeutic interventions for differentiated thyroid cancer, particularly in patients with radioiodine-refractory disease, by engaging thyroid-stimulating hormone receptors for individualized care. For example, in February 2024, the Personalized Medicine Coalition reported that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. Among these newly approved treatments, seven were for cancer and three for other diseases and conditions. As a result, the growing emphasis on personalized medicine is driving the Thyrogen market.
Key companies in the Thyrogen market are focusing on innovative applications, including its use as a theranostic tool for diagnosing and treating differentiated thyroid cancer. This approach enables companies to expand market share while addressing unmet medical needs in oncology. Thyrogen, as a theranostic tool, facilitates both diagnostic imaging and therapeutic interventions, particularly for patients with radioiodine-refractory disease, by targeting thyroid-stimulating hormone receptors. For instance, in June 2024, research published in the Journal of Nuclear Medicine by the Society of Nuclear Medicine and Molecular Imaging highlighted the expansion of Thyrogen's clinical applications through a theranostic approach, such as its potential use in diagnosing and treating radioiodine-refractory differentiated thyroid cancer (DTC) via targeted radiopharmaceuticals like [89Zr]Zr-Thyrogen. This development underscores the trend toward precision medicine, where diagnostic and therapeutic strategies are tailored to individual patient needs. Ongoing research and investment in recombinant TSH continue to support its adoption in emerging clinical scenarios, further driving market growth.
Major companies operating in the thyrogen market are Sanofi S.A.
North America was the largest region in the thyrogen market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyrogen market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the thyrogen market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
The thyrogen market consists of sales of products including, levothyroxine, radioactive iodine (I-131), proleukin, and Lugol's iodine solution. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Thyrogen Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses thyrogen market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for thyrogen ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The thyrogen market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Type: Vail; Pre-Filled
2) By Product Form: Thyrogen Powder; Thyrogen Injection
3) By Application: Diagnostic; Therapeutic
4) By End-User: Hospitals; Diagnostic Centers; Specialty Clinics; Other End-Users
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
6. Thyrogen Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Thyrogen Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Thyrogen PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Thyrogen Market Size, Comparisons And Growth Rate Analysis
7.3. Global Thyrogen Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Thyrogen Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Thyrogen Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Thyrogen Market Segmentation
9.1. Global Thyrogen Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Vail, Pre-Filled
9.2. Global Thyrogen Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Thyrogen Powder, Thyrogen Injection
9.3. Global Thyrogen Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Diagnostic, Therapeutic
9.4. Global Thyrogen Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Diagnostic Centers, Specialty Clinics, Other End-Users
10. Thyrogen Market Regional And Country Analysis
10.1. Global Thyrogen Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Thyrogen Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Thyrogen Market
11.1. Asia-Pacific Thyrogen Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Thyrogen Market, Segmentation By Type, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Thyrogen Market
12.1. China Thyrogen Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Thyrogen Market, Segmentation By Type, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Thyrogen Market
13.1. India Thyrogen Market, Segmentation By Type, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Thyrogen Market
14.1. Japan Thyrogen Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Thyrogen Market, Segmentation By Type, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Thyrogen Market
15.1. Australia Thyrogen Market, Segmentation By Type, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. South Korea Thyrogen Market
16.1. South Korea Thyrogen Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
16.2. South Korea Thyrogen Market, Segmentation By Type, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. Western Europe Thyrogen Market
17.1. Western Europe Thyrogen Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. Western Europe Thyrogen Market, Segmentation By Type, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. UK Thyrogen Market
18.1. UK Thyrogen Market, Segmentation By Type, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. Germany Thyrogen Market
19.1. Germany Thyrogen Market, Segmentation By Type, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. France Thyrogen Market
20.1. France Thyrogen Market, Segmentation By Type, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. Eastern Europe Thyrogen Market
21.1. Eastern Europe Thyrogen Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
21.2. Eastern Europe Thyrogen Market, Segmentation By Type, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. North America Thyrogen Market
22.1. North America Thyrogen Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
22.2. North America Thyrogen Market, Segmentation By Type, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. USA Thyrogen Market
23.1. USA Thyrogen Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
23.2. USA Thyrogen Market, Segmentation By Type, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Canada Thyrogen Market
24.1. Canada Thyrogen Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
24.2. Canada Thyrogen Market, Segmentation By Type, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. South America Thyrogen Market
25.1. South America Thyrogen Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
25.2. South America Thyrogen Market, Segmentation By Type, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Middle East Thyrogen Market
26.1. Middle East Thyrogen Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Middle East Thyrogen Market, Segmentation By Type, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Africa Thyrogen Market
27.1. Africa Thyrogen Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
27.2. Africa Thyrogen Market, Segmentation By Type, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. Thyrogen Market Regulatory and Investment Landscape
29. Thyrogen Market Competitive Landscape And Company Profiles
29.1. Thyrogen Market Competitive Landscape And Market Share 2024
29.1.1. Top 10 Companies (Ranked by revenue/share)
29.2. Thyrogen Market - Company Scoring Matrix
29.2.1. Market Revenues
29.2.2. Product Innovation Score
29.2.3. Brand Recognition
29.3. Thyrogen Market Company Profiles
29.3.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
30. Global Thyrogen Market Competitive Benchmarking And Dashboard
31. Key Mergers And Acquisitions In The Thyrogen Market
32. Thyrogen Market High Potential Countries, Segments and Strategies
32.1 Thyrogen Market In 2030 - Countries Offering Most New Opportunities
32.2 Thyrogen Market In 2030 - Segments Offering Most New Opportunities
32.3 Thyrogen Market In 2030 - Growth Strategies
32.3.1 Market Trend Based Strategies
32.3.2 Competitor Strategies
33. Appendix
33.1. Abbreviations
33.2. Currencies
33.3. Historic And Forecast Inflation Rates
33.4. Research Inquiries
33.5. The Business Research Company
33.6. Copyright And Disclaimer
(주)글로벌인포메이션02-2025-2992kr-info@giikorea.co.kr ⓒ Copyright Global Information, Inc. All rights reserved.
